Headlands Technologies’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.8K | Buy |
+7,184
| New | +$15.8K | ﹤0.01% | 963 |
|
|
2024
Q2 | – | Sell |
-9,493
| Closed | -$70.4K | – | 1251 |
|
|
2024
Q1 | $70.4K | Buy |
9,493
+7,861
| +482% | +$58.3K | 0.02% | 621 |
|
|
2023
Q4 | $16.5K | Buy |
+1,632
| New | +$16.5K | ﹤0.01% | 693 |
|
|
2023
Q3 | – | Sell |
-5,758
| Closed | -$47.4K | – | 995 |
|
|
2023
Q2 | $47.4K | Buy |
+5,758
| New | +$47.4K | 0.02% | 479 |
|